Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?
Open Access
- 11 February 2008
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 41 (11) , 935-940
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 2006
- Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agentsLeukemia, 2006
- Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDSBlood, 2004
- Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cellsBlood, 2003
- Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CMLBone Marrow Transplantation, 2003
- Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantationBlood, 2003
- Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomesTransplantation and Cellular Therapy, 2002
- The Treatment of Acute Myeloid Leukemia in First Relapse: A Comprehensive Review of the LiteratureLeukemia & Lymphoma, 2002
- The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantationBritish Journal of Haematology, 2000
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975